05/01/2026
Breakthrough research from the OSU College of Veterinary Medicine is helping uncover why some cancers resist treatment.
This new study identifies a key protein that could improve immunotherapy outcomes for children with aggressive neuroblastoma.
Read more:
A seminal research article titled “Cellular Identity Crisis: RD3 Loss Fuels Plasticity and Immune Silence in Progressive Neuroblastoma” has been published in the high-impact journal Advanced Science, offering important insights into why some neuroblastoma cancers become resistant to treatment.